Scientists have developed a gel for growing miniaturized body organs that can be used in clinical diagnostics and drug development. Organoids are miniature organs that can be grown in the lab from a person’s stem cells. They can be used to model diseases, and in the future could be used to test drugs or even replace damaged tissue in patients.
Scientists can now grow 3-D models of lungs from stem cells, creating new ways to study respiratory diseases, report scientists.
As part of an international clinical trial, researchers at the Sheffield Teaching Hospital recently reported interesting developments in multiple sclerosis therapy. Using the patients’ own blood stem cells, the scientists were able to reboot their immune system, therefore preventing autoreactive immune cells from further attacks on their fragile nervous system.
UT Southwestern Medical Center researchers successfully boosted the regeneration of mature nerve cells in the spinal cords of adult mammals — an achievement that could one day translate into improved therapies for patients with spinal cord injuries.
For people with a type of jaw joint disorder that results from loss of cartilage, the only treatments available address symptoms but do not repair the damaged tissue. Now, a new study of mice suggests stem cells already present in the jaw joint could be manipulated to repair it.
5-й зʼїзд Українського товариства клітинної біології з міжнародним представництвом
До уваги фахівців у галузі клітинної біології, мікробіології, молекулярної біології, біотехнології, імунології.
Всеукраїнська громадська організація “Українське товариство клітинної біології”, Інститут біології клітини НАН України повідомляють, що 02.10.2016 ‐ 06.10.2016 у м.Одеса на базі Одеського національного університету ім. І. Мечнікова за підтримки Національної академії наук України (НАН України) відбудеться черговий, 5-й зʼїзд Українського товариства клітинної біології з міжнародним представництвом (International Symposium on Cell Biology jointly with 5th Ukrainian Congress for Cell Biology).
The underlying cause of male infertility is unknown for 30 percent of cases. In a pair of new studies, researchers at University of California San Diego School of Medicine determined that the reproductive homeobox (RHOX) family of transcription factors — regulatory proteins that activate some genes and inactivate others — drive the development of stem cells in the testes in mice. The investigators also linked RHOX gene mutations to male infertility in humans. The mouse study is published September 27 by Cell Reports and the human study was published September 15 byHuman Molecular Genetics.
Using cell reprogramming techniques, scientists have managed to induce support cells in the retina to become stem cells capable of making new neurons. They suggest the technique could lead to new treatments for glaucoma, macular degeneration, and other eye diseases where retinal neurons are lost.
In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now. In a study published online today in Stem Cell Reports, researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have identified hepatocyte growth factor (HGF), secreted by MSCs, as the key factor responsible for promoting wound healing and reducing inflammation in preclinical models of corneal injury. Their findings suggest that HGF-based treatments may be effective in restoring vision in patients with severely scarred corneas.
A research team led by investigators at The Saban Research Institute of Children’s Hospital Los Angeles has generated functional human and mouse tissue-engineered liver from adult stem and progenitor cells. Tissue-engineered Liver (TELi) was found to contain normal structural components such as hepatocytes, bile ducts and blood vessels. The study has been published online in the journalStem Cells Translational Medicine.